Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction ...

Solute carrier (SLC) family transporters are crucial transmembrane proteins responsible for transporting various molecules, ...

The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

Hepatic steatosis, often triggered by non-alcoholic fatty liver disease (NAFLD), is a leading cause of liver dysfunction globally, affecting ...

A study revealed that about 84 per cent of Information Technology (IT) employees have Metabolic Dysfunction-Associated Fatty ...

The liver, essential for detoxifying the body and aiding digestion, can be damaged by excess fat accumulation, leading to ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD) ...

Liver: Early diagnosis of NAFLD is challenging because it often presents with no symptoms. In this article, we discuss how to ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reported two-year results from the open-label compensated MASH cirrhosis (F4c) ...

which is currently in a phase 2 clinical trial to test its efficacy in treating liver injury and fibrosis, although its clinical trial results are controversial. (4) Liraglutide is a GLP-1 receptor ...